O'Dell Group’s Pfizer PFE Stock Holding History

O'Dell Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,942	Closed	-$84.7K	–	363
2023 Q4	$84.7K	Buy	+2,942	New	+$88.9K	0.02%	156
2023 Q3	–	Sell	-892	Closed	-$32.7K	–	358
2023 Q2	$32.7K	Buy	+892	New	+$34.7K	0.01%	231
2022 Q4	–	Sell	-892	Closed	-$39K	–	301
2022 Q3	$39K	Hold	892	–	–	0.01%	161
2022 Q2	$47K	Hold	892	–	–	0.02%	154
2022 Q1	$46K	Hold	892	–	–	0.01%	184
2021 Q4	$53K	Buy	892 +166	+23%	+$8.22K	0.02%	161
2021 Q3	$31K	Buy	+726	New	+$32.2K	0.01%	199

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

O'Dell Group's PFE Position: Q1 2024 in Review

O'Dell Group sold out of Pfizer (PFE) in Q1 2024, closing a stake of 2,942 shares — an estimated $84.7K sold.

O'Dell Group first reported a position in PFE in Q3 2021 and held it in 7 quarters. The position peaked at $84.7K in Q4 2023. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

O'Dell Group reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
O'Dell Group sold 2,942 Pfizer shares in Q1 2024, an estimated $84.7K.
O'Dell Group first reported a position in Pfizer in Q3 2021 and held it in 7 quarters.
O'Dell Group's Pfizer position peaked at $84.7K in Q4 2023.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.